Olszewski, A. J., Avigdor, A., Babu, S., Levi, I., Eradat, H., Abadi, U., … Horowitz, N. A. (2022). Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma. In Blood (Vol. 140, pp. 1778–1780). American Society of Hematology. https://doi.org/10.1182/blood-2022-157768

Olszewski, Adam J., Abraham Avigdor, Sunil Babu, Itai Levi, Herbert Eradat, Uri Abadi, Houston Holmes, et al. “Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma.” In Blood, 140:1778–80. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-157768.

Olszewski AJ, Avigdor A, Babu S, Levi I, Eradat H, Abadi U, et al. Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma. In: Blood. American Society of Hematology; 2022. p. 1778–80.

Olszewski, Adam J., et al. “Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 1778–80. Crossref, doi:10.1182/blood-2022-157768.

Olszewski AJ, Avigdor A, Babu S, Levi I, Eradat H, Abadi U, Holmes H, McKinney M, Woszczyk D, Giannopoulos K, Jurczak W, Dunshee D, Yang A, Zhou M, Qayum N, Sellam G, Horowitz NA. Mosunetuzumab Monotherapy Continues to Demonstrate Promising Efficacy and Durable Complete Responses in Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma. Blood. American Society of Hematology; 2022. p. 1778–1780.